SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Vaxcyte’s XpressCF platform enables the development of broad-spectrum vaccines, overcoming the limitations of traditional cell-based approaches. VAX-31 and VAX-24 are Vaxcyte’s key value drivers. They ...
The need to develop antibiotics to combat growing antimicrobial resistance, combined with the difficulty of their discovery and the lack of financial support for their development, is a major ...
A new study has found that an extract made from willow bark, the precursor to aspirin, possesses effective broad-spectrum antiviral properties. The discovery may mean we will soon have a new way of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results